Tourmaline Bio, Inc. 3 SEC Filings

Filed On	Filing
28 Oct 2025	Form 3: Novartis Ag, 10% owner Holds 24,030,382 shares of Common Stock, par value $0.0001
15 Dec 2023	Form 3: Siegall Clay B, Director No securities owned
23 Oct 2023	Form 3: Thiara Parvinder, Director No securities owned
23 Oct 2023	Form 3: Robinson Ryan F., Interim CFO No securities owned
23 Oct 2023	Form 3: Middlekauff W Bradford, CBO, GC and Secretary No securities owned
23 Oct 2023	Form 3: Kulkarni Sandeep Chidambar, Director No securities owned
23 Oct 2023	Form 3: Kantoff Aaron, Director No securities owned
23 Oct 2023	Form 3: Jones Susan Dana, Chief Technology Officer No securities owned
23 Oct 2023	Form 3: Johnson Kevin Bruce, Chief Regulatory Officer No securities owned
23 Oct 2023	Form 3: Chyung Yung H., Chief Medical Officer No securities owned
23 Oct 2023	Form 3: Chester Cariad, Director No securities owned
23 Oct 2023	Form 3: Castelein Caley, Director No securities owned
17 May 2022	Form 3: Smith Karen L., Director No securities owned
06 May 2021	Form 3: Clarus Lifesciences III, L.p., 10% owner and 9 others
06 May 2021	Form 3: Agarwala Sandip, Director
06 May 2021	Form 3: Srivastava Sapna, Director
06 May 2021	Form 3: Clarus Defined Exit I, L.p., 10% owner and 9 others
06 May 2021	Form 3: Mcdade Mark, Director No securities owned
06 May 2021	Form 3: Galakatos Nicholas, Director No securities owned
06 May 2021	Form 3: Longitude Capital Partners III, Llc, 10% owner and 3 others

Comments